- $281.93m
- $296.25m
- $86.67m
- 55
- 28
- 71
- 51
Annual balance sheet for Sanara Medtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.455 | 18.7 | 8.96 | 5.15 | 15.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.27 | 2.99 | 7 | 8.53 | 13.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 4.48 | 24.6 | 20.6 | 19 | 33.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.15 | 2.04 | 2.22 | 3.25 | 1.88 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 9.83 | 36.4 | 61 | 73.9 | 88.1 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.54 | 6.02 | 12.8 | 13.8 | 15.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.68 | 5.76 | 19.2 | 29 | 48.7 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 6.15 | 30.6 | 41.8 | 44.8 | 39.4 |
Total Liabilities & Shareholders' Equity | 9.83 | 36.4 | 61 | 73.9 | 88.1 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |